← back to search

Lou Brundin

Karolinska Institutet · SE
Area of research
Pathology and Forensic Medicine · Developmental Neuroscience
Research interest
Research interests include Multiple Sclerosis Research Studies, Neurogenesis and neuroplasticity mechanisms, Neuroinflammation and Neurodegeneration Mechanisms, and Hearing, Cochlea, Tinnitus, Genetics.
h-index
45
citations
9,181
works
126
NIH funding
primary concept
email

Recent publications

Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis
Science Advances 2022cited by 47position: middledoi
Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions
Nature Communications 2021cited by 201position: middledoi
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial
The Lancet Neurology 2021cited by 106position: middledoi
Spinal Cord Injury Induces Permanent Reprogramming of Microglia into a Disease-Associated State Which Contributes to Functional Recovery
Journal of Neuroscience 2021cited by 63position: middledoi
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Neurology 2020cited by 104position: middledoi
Aggressive multiple sclerosis (1): Towards a definition of the phenotype
Multiple Sclerosis Journal 2020cited by 77position: middledoi
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
Scientific Reports 2020cited by 62position: middledoi
Aggressive multiple sclerosis (2): Treatment
Multiple Sclerosis Journal 2020cited by 41position: middledoi
Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 20position: middledoi
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
JAMA Neurology 2019cited by 750position: middledoi
Dynamics of oligodendrocyte generation in multiple sclerosis
Nature 2019cited by 369position: middledoi
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
Trials 2019cited by 93position: middledoi
Epidemiology of NMOSD in Sweden from 1987 to 2013
Neurology 2019cited by 64position: lastdoi
Neuronal methylome reveals CREB-associated neuro-axonal impairment in multiple sclerosis
Clinical Epigenetics 2019cited by 41position: middledoi
The Temporal Retinal Nerve Fiber Layer Thickness Is the Most Important Optical Coherence Tomography Estimate in Multiple Sclerosis
Frontiers in Neurology 2017cited by 60position: middledoi
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis
Neurology Neuroimmunology & Neuroinflammation 2016cited by 105position: middledoi
Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain
Cell 2014cited by 533position: middledoi
Nitric Oxide-Induced Neuronal to Glial Lineage Fate-Change Depends on NRSF/REST Function in Neural Progenitor Cells
Stem Cells 2014cited by 46position: lastdoi
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
Multiple Sclerosis Journal 2013cited by 165position: middledoi
Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
PLoS ONE 2013cited by 84position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jonas Faxén · Karolinska University Hospital4 papers (2014–2021)Fredrik Piehl · Karolinska University Hospital4 papers (2013–2019)Tomas Olsson · Karolinska University Hospital4 papers (2013–2020)Cynthia Pérez Estrada · Baylor College of Medicine3 papers (2014–2021)Jannis Kalkitsas · Karolinska Institutet2 papers (2020–2021)Maggie S. Y. Yeung · Karolinska Institutet2 papers (2014–2019)Mohsen Khademi · Karolinska University Hospital2 papers (2013–2016)Samuel Bernard · Université Claude Bernard Lyon 12 papers (2014–2019)Maja Jagodic · Karolinska University Hospital2 papers (2016–2019)Christian Göritz · Hong Kong Science and Technology Parks Corporation2 papers (2020–2021)Ramil Hakim · University of Indonesia2 papers (2019–2021)Eliane Piket · Karolinska University Hospital2 papers (2016–2019) · 2 papers (2014–2019)Yildiz Kelahmetoglu · General Medical Council2 papers (2020–2021)Jemal Tatarishvili · Lund University2 papers (2020–2021)Zaal Kokaia · Lund University2 papers (2020–2021)Robert A. Harris · Georgia Institute of Technology2 papers (2013–2021)Mikael Svensson · Karolinska University Hospital2 papers (2014–2021)David O. Dias · Karolinska Institutet2 papers (2020–2021) · 2 papers (2014–2019)